These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33354866)

  • 21. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
    Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE; Molleston JP; Newton KP; Whitington PF; Schwimmer JB;
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):438-446.e1. PubMed ID: 28286193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathology of nonalcoholic fatty liver disease.
    Brunt EM; Tiniakos DG
    World J Gastroenterol; 2010 Nov; 16(42):5286-96. PubMed ID: 21072891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ; Yi DY; Yang HR
    J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
    Kamada Y; Akita M; Takeda Y; Yamada S; Fujii H; Sawai Y; Doi Y; Asazawa H; Nakayama K; Mizutani K; Fujii H; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    PLoS One; 2013; 8(6):e66328. PubMed ID: 23805214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
    Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system.
    Zhou G; Zhao J; Ding X; Pan D; Sun Y; Yang J; Zhao Y
    Front Med China; 2007 Oct; 1(4):413-7. PubMed ID: 24573937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
    Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?
    Dillman JR; Trout AT; Costello EN; Serai SD; Bramlage KS; Kohli R; Xanthakos SA
    AJR Am J Roentgenol; 2018 Jan; 210(1):166-174. PubMed ID: 29045180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.
    Kleiner DE; Makhlouf HR
    Clin Liver Dis; 2016 May; 20(2):293-312. PubMed ID: 27063270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
    Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
    J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
    Sterling RK; Smith PG; Brunt EM
    J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
    Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.
    Parikh P; Patel J; Ingle M; Sawant P
    Indian J Gastroenterol; 2015 May; 34(3):200-8. PubMed ID: 26108652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.
    Vanderbeck S; Bockhorst J; Kleiner D; Komorowski R; Chalasani N; Gawrieh S
    Hum Pathol; 2015 May; 46(5):767-75. PubMed ID: 25776030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?
    Daltro C; Cotrim HP; Alves E; de Freitas LA; Araújo L; Boente L; Leal R; Portugal T
    Obes Surg; 2010 Nov; 20(11):1536-43. PubMed ID: 20556538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
    Tandra S; Yeh MM; Brunt EM; Vuppalanchi R; Cummings OW; Ünalp-Arida A; Wilson LA; Chalasani N
    J Hepatol; 2011 Sep; 55(3):654-659. PubMed ID: 21172393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.
    Ampuero J; Aller R; Gallego-Durán R; Crespo J; Abad J; González-Rodríguez Á; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Martín-Mateos R; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Hernández-Guerra M; Augustín S; Pareja-Megia MJ; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero-Gómez M;
    Liver Int; 2021 Sep; 41(9):2076-2086. PubMed ID: 33896100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.